Melanoma (Skin Cancer)
Oncology·MeSH: Melanoma
Prevalence
75.0 / 100K
Incidence
23.0 / 100K/yr
4 drugs in development·2 companies·5 clinical trials
Drug Pipeline by Phase
Phase 3(1)
Phase 2(1)
Phase 2/Phase 3(2)
Compare drugs
Frequently asked questions
How many drugs are in development for Melanoma (Skin Cancer)?
BioSniper tracks 4 drugs in development for Melanoma (Skin Cancer) across 2 companies.
How many clinical trials target Melanoma (Skin Cancer)?
There are 5 clinical trials targeting Melanoma (Skin Cancer) tracked by BioSniper.
What is the prevalence of Melanoma (Skin Cancer)?
The estimated prevalence of Melanoma (Skin Cancer) is approximately 75.0 per 100,000 population.
Deep-dive into Melanoma (Skin Cancer)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis